Antiretroviral therapy in early HIV infection.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Entering HIV Medical Care With AIDS in the Era of Immediate Access to Antiretroviral Treatment.Journal of acquired immune deficiency syndromes (1999) · 2025
   Article
2. Trends and disparities in antiretroviral therapy prescription rates among US Medicare beneficiaries with HIV.HIV medicine · 2025
   Article
3. Comparison of Immunological and Virological Recovery with Rapid, Early, and Late Start of Antiretroviral Treatment in Naive Plwh: Real-World Data.International journal of general medicine · 2023
   Article
4. Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection.BMC medical ethics · 2021
   Article
5. The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus.Purinergic signalling · 2021
   Review
6. Clinico-Immunological Status and Neurocognitive Function of Perinatally Acquired HIV-Positive Children on cART: A Cross-Sectional Correlational Study in South Africa.Frontiers in neurology · 2020
   Article
7. Implementation of an Immediate HIV Treatment Initiation Program in a Public/Academic Medical Center in the U.S. South: The Miami Test and Treat Rapid Response Program.AIDS and behavior · 2019
   Article
8. Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8Immunity, inflammation and disease · 2018
   Article
9. HIV therapeutic vaccines: moving towards a functional cure.Current opinion in immunology · 2015
   Review
10. Determinants of antiretroviral therapy coverage in Sub-Saharan Africa.PeerJ · 2015
    Article
11. Antiretroviral therapy: when to start.Infectious disease clinics of North America · 2014
    Review
12. Clinical development of candidate HIV vaccines: different problems for different vaccines.AIDS research and human retroviruses · 2014
    Review
13. Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention.AIDS research and human retroviruses · 2014
    Review
14. Early treatment and HIV-1 reservoirs: a stitch in time?The Journal of infectious diseases · 2013
    Article
15. Monocyte/macrophages and their role in HIV neuropathogenesis.Immunological reviews · 2013
    Review

Corrections and comments

• Comment on
  Short-course antiretroviral therapy in primary HIV infection.2013
• Comment on
  Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.2013

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as